1. Home
  2. INSG vs ABOS Comparison

INSG vs ABOS Comparison

Compare INSG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$9.92

Market Cap

190.1M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.33

Market Cap

165.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
ABOS
Founded
1996
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
165.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
INSG
ABOS
Price
$9.92
$2.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$15.33
$8.00
AVG Volume (30 Days)
411.6K
360.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$313,832,000.00
N/A
Revenue This Year
$16.21
N/A
Revenue Next Year
$13.28
N/A
P/E Ratio
$15.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$1.10
52 Week High
$21.90
$3.60

Technical Indicators

Market Signals
Indicator
INSG
ABOS
Relative Strength Index (RSI) 34.45 47.71
Support Level $9.44 $2.14
Resistance Level $11.81 $2.43
Average True Range (ATR) 0.84 0.15
MACD -0.07 0.02
Stochastic Oscillator 2.46 53.16

Price Performance

Historical Comparison
INSG
ABOS

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: